| Literature DB >> 25317221 |
Parana H M Jayathunge1, William J H McBride1, David MacLaren1, John Kaldor2, Andrew Vallely2, Stuart Turville2.
Abstract
Male circumcision (MC) has been shown to be protective against heterosexual HIV transmission and is being explored in some parts of the world as a means of combating the epidemic. The World Health Organization (WHO) recommends that MC be considered as an important component of HIV prevention in high prevalence settings. We review evidence that demonstrates that the inner foreskin is likely to be the main portal of entry for the HIV virus in males. Whether removal of the inner foreskin accounts for all the protection afforded by circumcision is yet to be established. The proposed mechanisms of protection range from inherent immunohistological factors of foreskin such as difference in thickness of keratin layer and density of target cells for HIV between inner and outer foreskin to physiological mechanisms that follow male circumcision such as drying of secretions underneath foreskin after sexual intercourse, loss of microbiome that attract target cells to the genital mucosa and lack of priming the genital mucosa with less abundant sexual transmitted infections among circumcised men. The aim of this review is to give an updated account on the mechanisms proposed so far on the demonstrated 50-70% protection from HIV transmission through heterosexual intercourse, by male circumcision.Entities:
Keywords: Circumcision; HIV transmission; foreskin; immune cells; keratin layer.
Year: 2014 PMID: 25317221 PMCID: PMC4192839 DOI: 10.2174/1874613601408010031
Source DB: PubMed Journal: Open AIDS J ISSN: 1874-6136
Summary of studies that examined the keratin thickness of the foreskin.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| 14 subjects10 months - 69years from Chicago, USA |
Phimosis, Balanitis,
Adhesions (3 subjects) | Not specified | Processed within: 3 hours Fixed with: Streck Tissue Fixative Embedded in: Paraffin or OCT Section size: 5µm Stained with: immunohistochemistry Examined with: MetaMorph software V4.5 |
|
|
|
9
cadavers† | Not specified | HIV negative | Processed within: necropsy specimens obtained within 18 hours of death Fixed with: Formalin Embedded in: Paraffin Section size: 8µm Stained with: H & E stains and Ayoub-Shklar stains Examined with: Light microscopy 200-400 magnification |
|
|
|
80
subjects, 60
were 2-7 years | Phimosis or redundant foreskin with UTI (30 boys) Cultural or cosmetic (30 boys) Not specified for adults who were otherwise healthy | Not specified | Processed within: Not specified Fixed with: 4% Para formaldehyde Embedded in: Paraffin Section size: 4µm Stained with: H & E Examined with: Light microscopy 100-400 magnification |
|
|
| 16 subjects† from Chicago, USA | Phimosis | Not specified | Processed within: Not specified Fixed with: 3.7% Formaldehyde, 0.1mol/l PIPES buffer Embedded in: Paraffin, OCT Section size: 10µm ( cryosections) Stained with: immunofluorescence and H & E Examined with: DeltaVision RT systems using Softworx software |
|
|
| 19 subjects 21-41 years from Rakai, Uganda | As prophylactic measure for HIV acquisition | HIV negative No evidence of current STIs | Processed within: Not specified Fixed with: 3.7% Formaldehyde, 0.1mol/l PIPES buffer Embedded in: OCT Section size: 10 µm Stained with: immunofluorescence and H & E Examined with: DeltaVision RT systems using Softworx software |
|
Age range not specified.
(IFS, inner foreskin; OFS, outer foreskin; LC, Langerhans cells STI, sexually transmitted infection PBS, phosphate buffered solution OCT, Optimum Cutting Temperature).
Studies that examined target cell distribution in foreskin tissues.
|
|
|
|
|
|
|---|---|---|---|---|
|
|
10 subjects, 7 subjects, 3-7 weeks | Not Specified | Not specified |
|
|
| 14 subjects, 10 months- 69 years from Chicago, USA | Phimosis, balanitis, adhesions and redundant foreskins. | Not specified |
|
|
|
30 subjects, |
| HIV negative |
|
|
| 39 subjects, 18-24 years from Kisumu, Kenya | Foreskins obtained from the randomised controlled trial in Kenya [3]. | 21 men without history of STI 19 men with a history of treated STI |
Epidermis † Dermis † LC cells
1.23% 0.30 % CD4 T cells
0.08% 0.075% Macrophages
0.02% 0.04% |
|
|
80 subjects, 60 subjects , 2-7
years 20 subjects, 20-29 years |
| Not specified |
|
|
| Subjectsfy (number of subjects or age range not specified) from London, UK | Elective circumcisions after gender reassignment (after 6 weeks off hormonal therapy). | Not specified |
|
|
| 33 subjects, 18-24 years from Kisumu, Kenya | Foreskins obtained from the randomised controlled trial in Kenya [3]. | All men were negative for STI for a period of 3 months prior circumcision. |
|
|
| Subjectsy (number of subjects not specified) 17-87years from Paris, France | Personal reasons or phimosis | Foreskins with history of infectious pathologies were not used. |
|
(IFS, inner foreskin; OFS, outer foreskin; LC, Langerhans cells; STI, sexually transmitted infection; UTI, urinary tract infection).
ϕage range not specified Ψ number of subjects not specified *percentages were based on the number of brown staining cells indicating a specific immunophenotypic marker divided by the total number of nucleated cells †The mean cell percentages were derived from the amount of cellular area staining positive per total cellular area in 5 fields covering the IFS containing 50%epithelium and 50%dermis within each field. γPrimary data not given.
Studies on tissue explants to examine early stages of HIV-1 transmission.
IFS, inner foreskin; OFS, outer foreskin; LC, Langerhans cells STI, sexually transmitted infection.